← All diseases

Disease Atlas / Disease detail

Hepatitis C virus infection

This educational material summarizes the essentials of HCV infection transmission, progression, diagnosis, treatment, and evidence interpretation.

hepatitis C virus infection · Hepatitis C virus caused hepatitis · Hepatitis C virus hepatitis · NANBH · chronic hepatitis C · hepatitis C infection · hepatitis type C · non-A, non-B Hepatitis

MONDO:0005231Public QA completeSource-bound · 4

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · be6ceab37983

Disease category
Hepatitis C virus (HCV) infection causes liver inflammation and is an infectious disease that can present as acute or chronic.
Key mechanism
The primary route of transmission is contact with the blood of an infected person, and contaminated syringes, tattooing tools, personal items, childbirth, and certain sexual contacts may be involved.
Main causes · related factors
Liver inflammation caused by HCV infection can damage liver tissue, and if the infection persists, it can lead to fibrosis and cirrhosis.
Representative patterns
Many people are asymptomatic, but during the acute phase, symptoms such as fatigue, fever, nausea, abdominal pain, joint pain, dark urine, and jaundice may appear.
Individual differences
Risk factors that can increase the risk include intravenous drug use, past blood transfusions or organ transplants, hemodialysis, blood exposure in medical settings, HIV infection, and birth to an infected mother; the course varies by individual.
Diagnosis
Acute infection can last up to 6 months and may resolve spontaneously, but in many cases it becomes chronic, with complications potentially manifesting decades later.
Management
Diagnosis is based on confirming exposure and medical history, physical examination, and blood tests, and if necessary, additional tests for assessing liver damage are also performed.
Treatment/Research Status
As many cases are asymptomatic, infection cannot be ruled out based solely on the presence or absence of symptoms, and test results must be interpreted by considering both the timing of infection and the degree of liver damage.
Read Evidence
The key to management is reducing complications through early detection and antiviral treatment, and appropriately evaluating and managing concomitant issues such as liver cirrhosis or liver cancer.
Key Precautions
Current treatment centers on antivirals, and it is advised that the infection can be treated in most cases.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a Glance

Hepatitis C virus (HCV) infection causes liver inflammation and is an infectious disease that can present as acute or chronic.

Many people are asymptomatic, but during the acute phase, symptoms such as fatigue, fever, nausea, abdominal pain, joint pain, dark urine, and jaundice may appear.

How the disease works

The primary route of transmission is contact with the blood of an infected person, and contaminated syringes, tattooing tools, personal items, childbirth, and certain sexual contacts may be involved.

Liver inflammation caused by HCV infection can damage liver tissue, and if the infection persists, it can lead to fibrosis and cirrhosis.

Variations in presentation among individuals

Risk factors that can increase the risk include intravenous drug use, past blood transfusions or organ transplants, hemodialysis, blood exposure in medical settings, HIV infection, and birth to an infected mother; the course varies by individual.

The broad framework of diagnosis and management

Acute infection can last up to 6 months and may resolve spontaneously, but in many cases it becomes chronic, with complications potentially manifesting decades later.

Diagnosis is based on confirming exposure and medical history, physical examination, and blood tests, and if necessary, additional tests for assessing liver damage are also performed.

Current status of treatment

As many cases are asymptomatic, infection cannot be ruled out based solely on the presence or absence of symptoms, and test results must be interpreted by considering both the timing of infection and the degree of liver damage.

The key to management is reducing complications through early detection and antiviral treatment, and appropriately evaluating and managing concomitant issues such as liver cirrhosis or liver cancer.

Current treatment centers on antivirals, and it is advised that the infection can be treated in most cases.

How to read clinical trials

Follow-up may include blood tests and imaging tests for assessing liver damage, and treatment effectiveness, positive outcomes, or whether it is standard care should not be judged solely by clinical trial registration.

Points to verify during clinical consultations

In clinical practice, it is important to assess past blood exposure, transfusions/transplants/dialysis, injection drug use, sexual and childbirth-related risks, symptoms, presence of liver damage, and treatment and follow-up plans.

Medical Guidance

This material is for educational purposes and is not intended as guidance for individual diagnosis or treatment.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.